Tagged: "pharmaceuticals"

SWFI Event

Current News

Page 1 of 2
08/19/2020

INFLATED PRICES: Drug Maker Teva Pharmaceuticals Gets Caught up in Alleged Kickbacks

07/23/2020

Taro Pharmaceuticals U.S.A. Charged by DOJ in Ongoing Criminal Antitrust Investigation

04/13/2020

Blackstone Takes a Strategic Gamble on Alnylam Pharmaceuticals

05/29/2019

Ayala Pharmaceuticals Raises Series B Round

04/17/2018

Temasek Subscribes to Roughly 3.6% of Bayer AG

03/02/2018

SWFI Institutional Investor Forum 2018 – Santa Monica Slider10

11/30/2017

Two Sovereign Funds Back Series C in Codiak BioSciences

08/10/2016

Malaysian Sovereign Wealth Backs Bay Area Pharma Company

03/02/2016

Institutional Investors: Winners and Losers if Trump Wins

02/26/2016

Australia’s Future Fund Takes a Page from Alaska

01/27/2016

Alaskan SWF Invests in Series B on Anti-Cancer Biotech

12/07/2015

Temasek Leads Series C in ASLAN Pharmaceuticals

11/22/2015

Sovereign Fund Direct Investing in Healthcare Remains Constant

09/03/2015

Middle East Sovereign Fund Boosts Position in Mylan

06/30/2015

See Why the Alaska Permanent Fund is Smiling

06/22/2015

Temasek and CVC Capital Partners Acquire Majority Stake in Alvogen

05/14/2015

REPEAT: Alaska Permanent Fund Takes Stake in Denali Therapeutics

04/27/2015

COMPETITION: Sovereign Wealth Funds Spice Up Deal Activity in Asia

04/17/2015

Temasek Allocates $150 Million in Indian Pharma Company

02/19/2015

$130 Million To $1 Billion, APFC’s Unrealized Gain on Juno

Get News, People, and Transactions, Delivered to Your Inbox